Byrgazov K, Lucini CB, Valent P, Hantschel O, Lion T. BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib. Haematologica [Internet]. 2017Dec.31 [cited 2026Nov.10];103(1):e10-e12. Available from: https://haematologica.org/article/view/8329